MRPL15 was consistently highly expressed in ovarian tumours compared to normal tissue; significantly associated with late stage disease, and was associated with poor survival when compared to patients with low MRPL15 expression [26]. This evidence concerns the gene MRPL15 and ovarian neoplasm.